Relapsed or refractory myeloid malignancies Clinical Trials
Conditions / Relapsed or refractory myeloid malignancies
Delta Trials tracks 1 clinical trial for Relapsed or refractory myeloid malignancies in its publicly accessible dataset. Among the listed trials, 0 open for participant enrollment and 1 trial have reached completion. This research is carried out at 11 clinical sites around the world. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
1
Total Trials
0
Recruiting
1
Completed
0
Other Active
0
Terminated since 2020
11
Study Locations
Browse by location (11 total)
- Philadelphia, United States 1 trialAll trials in Philadelphia, United States
- Boston, United States 1 trialAll trials in Boston, United States
- Stanford, United States 1 trialAll trials in Stanford, United States
- Denver, United States 1 trialAll trials in Denver, United States
- Salt Lake City, United States 1 trialAll trials in Salt Lake City, United States
- New York, United States 1 trialAll trials in New York, United States
- Houston, United States 1 trialAll trials in Houston, United States
- Glasgow, United Kingdom 1 trialAll trials in Glasgow, United Kingdom
- Atlanta, United States 1 trialAll trials in Atlanta, United States
- London, United Kingdom 1 trialAll trials in London, United Kingdom
- Ann Arbor, United States 1 trialAll trials in Ann Arbor, United States